COVID-19 incubation period potentially much longer than previously thought

Researchers at Trinity College Dublin have provided an updated estimate of the incubation period for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent causes coronavirus disease 2019 (COVID-19).

Initial estimates made during the early stages of the pandemic ranged from around 4 to 7 days.

However, numerous reports have since emerged, estimating an incubation period of anything from one to 34 days.

Currently, governments are planning their mitigation strategies based on a maximum incubation period of 14 days.

Now, Prakashini Banka and Catherine Comiskey have conducted a modeling study highlighting the variability in this period, including the potential for incubation that extends beyond 14 days.

An accurate estimate of the incubation period distribution for SARS-CoV-2 is essential for modeling the virus's spread and the effectiveness of control measures.

Banka and Comiskey warn that since the incubation period may be longer than initially estimated, detailed surveillance of self-isolation periods and other protective measures is now needed.  

A pre-print version of the paper is available on the server medRxiv*, while the article undergoes peer review.

This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (pink) cultured in the lab. Image captured and colorized at NIAID
This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (pink) cultured in the lab. Image captured and colorized at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana. Credit: NIAID

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

The challenges faced in modeling the spread of SARS-CoV-2

Early estimates of the SARS-CoV-2 incubation period ranged from 4.0 to 6.4 days, but since then, several studies have estimated that incubation periods range from one to 34 days.

When an epidemic results in both symptomatic and asymptomatic infections, it becomes difficult to establish disease prevalence and transmission.

"Mathematical modeling of the effective reproductive number R of an epidemic, the spread of infection, and the subsequent decisions on planning and mitigation is fully dependent on accurate and up to date estimates of the key modeling parameters," say the researchers.

Given the improvements in surveillance and monitoring since the first cases were identified, Banka and Comiskey have now conducted a scoping review and meta-analysis of the parameters of the global incubation period of COVID-19.

The aim was to provide an updated estimate of the incubation period distribution that will help improve modeling estimates of the effective reproductive number R and, in turn, estimates of the prevalence of asymptomatic cases.

What did the researchers do?

The team searched five databases, including CINAHL, MEDLINE, PUBMED, EMBASE, ASSIA, and Global Index Medicus for studies published between January 1st, 2020, and July 27th, 2020.

After screening the articles, 64 were included, covering a total of 45,151 people aged 0 to 90 years, with a median age of 43 years.

The minimum incubation period ranged from 1 to 9 days and the maximum incubation period ranged from 4 to 34 days. The mean incubation period (based on 30 studies) was 6.71, with 95% confidence intervals ranging from 1 to 12.4 days.

A confidence interval (CI) is an estimate that indicates the range of values that the actual value could lie within. Therefore, the CI helps to quantify the uncertainty of an estimate when the true value cannot be known.

The median incubation period (based on 58 studies) was 6 days, with an interquartile range (IQR) of 1.8 to 16.3.

The IQR is a measure of where the middle 50% of values lie in a data set, indicating where most values lie. The smaller the IQR, the closer the data are to the median, while the larger the IQR, the further the data are spread from the median.

Banka and Comiskey say this study has found that the mean incubation period may be significantly longer than has previously been estimated.

"The findings highlight the variability in the mean period and the potential for further incubation beyond 14 days," they write.

It is essential to maintain an accurate and updated estimate

The researchers say it is essential to maintain an accurate and up-to-date estimate of the SARS-CoV-2 incubation period as the virus continues to spread so that mitigation measures and advice to the general public can be properly planned.

"It is equally essential that the mitigation strategies on affected communities and hospital planning requirements that are determined from modeling scenarios are based on reliable and accurate global estimates of the incubation period," they add.

"There is an ongoing need for detailed surveillance on the timing of self-isolation periods and related measures protecting communities as incubation periods may be longer," concludes the team.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2020, October 25). COVID-19 incubation period potentially much longer than previously thought. News-Medical. Retrieved on November 09, 2024 from https://www.news-medical.net/news/20201025/COVID-19-incubation-period-potentially-much-longer-than-previously-thought.aspx.

  • MLA

    Robertson, Sally. "COVID-19 incubation period potentially much longer than previously thought". News-Medical. 09 November 2024. <https://www.news-medical.net/news/20201025/COVID-19-incubation-period-potentially-much-longer-than-previously-thought.aspx>.

  • Chicago

    Robertson, Sally. "COVID-19 incubation period potentially much longer than previously thought". News-Medical. https://www.news-medical.net/news/20201025/COVID-19-incubation-period-potentially-much-longer-than-previously-thought.aspx. (accessed November 09, 2024).

  • Harvard

    Robertson, Sally. 2020. COVID-19 incubation period potentially much longer than previously thought. News-Medical, viewed 09 November 2024, https://www.news-medical.net/news/20201025/COVID-19-incubation-period-potentially-much-longer-than-previously-thought.aspx.

Comments

  1. Helen Garlinge Helen Garlinge United Kingdom says:

    After incubation period is over, I've heard something about a 90day window where cells are still active, is this true?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients